GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kingchem (Liaoning) Life Science Co Ltd (SZSE:301509) » Definitions » Equity-to-Asset

Kingchem (Liaoning) Life Science Co (SZSE:301509) Equity-to-Asset : 0.94 (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Kingchem (Liaoning) Life Science Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kingchem (Liaoning) Life Science Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was ¥2,137.9 Mil. Kingchem (Liaoning) Life Science Co's Total Assets for the quarter that ended in Jun. 2024 was ¥2,283.8 Mil. Therefore, Kingchem (Liaoning) Life Science Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.94.

The historical rank and industry rank for Kingchem (Liaoning) Life Science Co's Equity-to-Asset or its related term are showing as below:

SZSE:301509' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.59   Med: 0.78   Max: 0.95
Current: 0.94

During the past 6 years, the highest Equity to Asset Ratio of Kingchem (Liaoning) Life Science Co was 0.95. The lowest was 0.59. And the median was 0.78.

SZSE:301509's Equity-to-Asset is ranked better than
96.9% of 1066 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs SZSE:301509: 0.94

Kingchem (Liaoning) Life Science Co Equity-to-Asset Historical Data

The historical data trend for Kingchem (Liaoning) Life Science Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kingchem (Liaoning) Life Science Co Equity-to-Asset Chart

Kingchem (Liaoning) Life Science Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.64 0.66 0.78 0.73 0.94

Kingchem (Liaoning) Life Science Co Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.89 0.94 0.95 0.94

Competitive Comparison of Kingchem (Liaoning) Life Science Co's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Kingchem (Liaoning) Life Science Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kingchem (Liaoning) Life Science Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kingchem (Liaoning) Life Science Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Kingchem (Liaoning) Life Science Co's Equity-to-Asset falls into.



Kingchem (Liaoning) Life Science Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Kingchem (Liaoning) Life Science Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=2171.005/2310.636
=0.94

Kingchem (Liaoning) Life Science Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=2137.947/2283.809
=0.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kingchem (Liaoning) Life Science Co  (SZSE:301509) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Kingchem (Liaoning) Life Science Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Kingchem (Liaoning) Life Science Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kingchem (Liaoning) Life Science Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Anren Road, Fluorine Chemical Industry Park, Yimatu Town, Fumeng, Liaoning, Fuxin, CHN, 123000
Kingchem (Liaoning) Life Science Co Ltd is engaged in Customized research & development and production services for small molecule drug intermediates and a small amount of raw materials. It is a key manufacturer of fluoro-organic compounds in China and is capable of using HF, KF, and highly selective fluorinating agents at a commercial scale.

Kingchem (Liaoning) Life Science Co Headlines

No Headlines